Citi analyst Daniel Grosslight raised the firm’s price target on Teladoc (TDOC) to $10.50 from $9.50 and keeps a Neutral rating on the shares as part of a Q3 earnings preview. Citi is “encouraged” by third-party data regarding Teladoc’s trends and believes BetterHelp’s results will surprise to the upside.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC: